Sanofi India Limited (BOM: 500674)

Market Cap	142.23B
Revenue (ttm)	28.23B
Net Income (ttm)	4.60B
Shares Out	23.03M
EPS (ttm)	199.60
PE Ratio	26.82
Forward PE	n/a
Dividend	167.00 (2.70%)
Ex-Dividend Date	n/a

Volume	534
Open	6,100.00
Previous Close	6,100.70
Day's Range	6,091.35 - 6,219.70
52-Week Range	5,850.55 - 10,526.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 21, 2025

About Sanofi India

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through indepe...

• Industry: Pharmaceutical Preparations
• Founded: 1956
• Employees: 2,174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500674

Financial Performance

In 2023, Sanofi India's revenue was 28.51 billion, an increase of 2.92% compared to the previous year's 27.70 billion. Earnings were 6.03 billion, a decrease of -2.85%.